Loading...
Market
FDA Approval for AVATAR Therapy in Psychosis Treatment by 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
FDA announcements and approvals
Story
Nature Medicine Study Shows AVATAR Therapy Benefits for Psychosis and Schizophrenia Patients
Oct 28, 2024, 09:31 PM
A recent study published in Nature Medicine highlights the potential benefits of AVATAR therapy for individuals suffering from psychosis and schizophrenia. This innovative approach involves the use of digital avatars to represent the auditory hallucinations experienced by patients. By engaging with a digital embodiment of the voices they hear, patients can confront and manage these distressing experiences. The therapy has been shown to lead to short-term improvements in voice-related distress and empower patients to regain control of their lives. The study emphasizes the therapeutic potential of using avatars in psychosis therapy, offering a new avenue for treatment for those who hear bullying or abusive voices. Psychologists played a key role in helping patients construct these avatars.
View original story
Similar markets
AbbVie • 25%
Bristol Myers Squibb • 25%
Another major pharmaceutical company • 25%
No new approvals • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
No new competitors • 25%
1 new competitor • 25%
2 new competitors • 25%
3 or more new competitors • 25%
None • 25%
One • 25%
Two • 25%
Three or more • 25%
